All products regulated by the Food and Drug Administration (FDA) that are imported into the United States will now be subject to inspection, according to a new policy from US Customs and Border Protection (CBP). Read More »

PCCA has announced the release of UniFlow, a new powder excipient base designed for compounding triturations with highly potent, low-dose active pharmaceutical ingredients such as liothyronine sodium (T3) and levothyroxine sodium (T4). Read More »

On October 6, 2025, the Acting Director of the Centers for Disease Control and Prevention (CDC) accepted recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding the COVID-19 vaccine. Read More »

The North Carolina Board of Pharmacy is preparing for its upcoming election for the southeastern district position. Read More »

PCCA recognized four individuals for their contributions to pharmacy compounding during its ThinkNext: International Seminar 2025, held October 9-11 in The Woodlands, Texas. Read More »

The North Carolina Board of Pharmacy (NCBOP) has announced a change in the schedule for public input on proposed amendments to rule 21 NCAC 46 .1418, which concerns health care facility pharmacy technicians. Read More »

A group of organizations representing independent pharmacies has filed a legal brief in support of Iowa's regulation of pharmacy benefit managers (PBMs), which is currently being challenged in federal court. Read More »

Bristol Myers Squibb and the National Community Pharmacists Association (NCPA) have announced a new partnership to improve heart health in rural areas of the United States. Read More »

The South Dakota Department of Health (DOH) is inviting middle and high school students to participate in Scrubs Camps and Camp Meds, programs designed to introduce young people to careers in healthcare. Read More »

President Trump has announced an agreement with Pfizer to reduce drug prices in the United States. Read More »

BPI Labs has announced its collaboration with Empower Pharmacy to challenge Eli Lilly's patent on tirzepatide. Read More »

The National Community Pharmacists Association (NCPA) has voiced strong opposition to a reported proposal that would allow pharmacy benefit managers (PBMs) to self-regulate. Read More »

The Nurses United for Healthcare Integrity (NUHI) has raised concerns about the exploitation of the 340B Drug Pricing Program by hospitals. Read More »

The South Dakota Health Link will hold its 2025 Fall Forum through a series of three virtual sessions. Read More »

The Virginia Department of Health has announced a new statewide standing order signed by State Health Commissioner Karen Shelton, MD, on September 10. Read More »

The National Community Pharmacists Association (NCPA) has announced a series of upcoming events and educational opportunities for pharmacists and pharmacy teams. Read More »

The National Community Pharmacists Association (NCPA) has responded to the Federal Trade Commission’s decision to appoint Emma Mittelstaedt Burnham as associate director of health care in the Bureau of Competition. Read More »

The National Community Pharmacists Association (NCPA) has sent a letter to Congressional leaders, representing a coalition of 134 organizations that include patient groups, health care providers, employers, business groups, and union workers. Read More »

Nearly one in five independent pharmacists say they will not stock drugs included in the Medicare Drug Price Negotiation Program, and another 67 percent report they may also choose not to participate. Read More »

Dutch Rojas, founder of ReKlaim Health, said that the 340B program has deviated from its original mission to assist low-income patients and instead allows health systems to profit from drug pricing arbitrage. Read More »